Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
LungFlex AB
AB
Active
Org 5568551419
Garvaren, 341 60
Ljungby
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 15 years old
0 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
LungFlex AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
1M
2024
0M
2025
EBITDA
SEK millions
0M
-1M
-1M
-2M
-3M
0M
2021
-1M
-100%
2022
-1M
0%
2023
-1M
0%
2024
-2M
-100%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
53
158
168
585
278
Staff expenses
—
−9
−11
−113
−0
EBITDA
−365
−828
−745
−1 383
−1 675
Depreciation & amort.
−0
−55
−55
−55
−55
EBIT
−365
−882
−800
−1 437
−1 730
Net financials
−42
−35
−32
−49
−186
Profit before tax
−407
−917
−832
−1 486
−1 916
Tax
−0
—
—
—
—
Net profit
−407
−917
−832
−1 486
−1 916
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 951
2 707
1 624
1 711
1 804
Equity
1 390
2 035
1 204
367
−348
Long-term debt
349
218
86
1 007
2 000
Short-term debt
212
454
334
337
153
Total debt
561
671
420
1 343
2 153
Financial ratios
5-year trend
EBITDA-margin
-602.6%
This company
15.8%
Market median
-3914% vs market
2021
2025
Soliditetsgrad
-19.3%
This company
38.2%
Market median
-151% vs market
2021
2025
Egenkapitalforrentning
-191555000.0%
This company
18.4%
Market median
-1041059883% vs market
2021
2025
Nettoresultatgrad
-689.1%
This company
8.1%
Market median
-8607% vs market
2021
2025
Aktivomsætning
0.15×
This company
1.12×
Market median
-87% vs market
2021
2025
Gæld/egenkapital
6.18×
This company
0.62×
Market median
-897% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
View
PDF
More on LungFlex AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
